IbisVision, the Glasgow-based company that's leading the move to remote and over-the-Internet eyecare, has unveiled breakthrough technology, the first of its kind, that allows for optometrists to determine a prescription over the Internet, with hardware that’s a fraction of the cost of traditional eyecare systems.
The company, backed by a consortium led by Miami-based Compiler VC in a recent $5.6 million funding round, will launch its updated Ibis-Connect platform at the Vision Expo West conference in Las Vegas later this month. It is envisaged that many of the larger US optical players, as well as regional operators and independent optical businesses, will be interested in what is the first truly objective over-the-Internet technology from which to prescribe corrective lenses.
Not only does the system just require a simple internet connection, the patient uses a proprietary Remote Refraction Tool (RRT) that costs a few cents to produce, compared to the traditional machines that can cost thousands of dollars for opticians to acquire. The system aligns with IbisVision’s philosophy of delivering eyecare and treatment over the Internet, while maintaining clinical excellence and the full involvement of eyecare professionals.
The platform, which is currently undergoing rigorous clinical trials, can work through the most basic of computers and Internet connections and uses a simple and intuitive interface to ensure high quality reliable readings from the patient, all overseen by eyecare professionals based wherever the optometry business chooses.
The technology builds on IbisVision’s existing eye-health Internet platform, whose capabilities have expanded from a single test to now offering 11 different eye exams, and bases its accuracy on being able to continually measure the patient’s distance from the camera on their computer. Ultimately, the technology allows for a full end-to-end remote experience for patients who may be too busy or find it difficult to attend a clinic in person.
The issuing of prescriptions can be combined with existing technology that allows patients to try various glasses virtually to find the best fit, look and style.
The company is ready to engage with clients – it’s FDA listed, CE marked and HIPAA compliant – and has opened an office in Miami to oversee its business throughout the US.
Commenting on the launch, IbisVision CEO Mark Roger said "This is the breakthrough we've all been waiting for – allowing an optometrist to test for and issue a prescription online. This opens up huge potential not only in making eyecare available to all, but in turbocharging e-commerce behind the optometry industry, and allowing for optometrists to serve communities without investing vast amounts in cumbersome machinery. We’re delighted to be launching this at the world's biggest optometry Expo where we expect to receive strong support and interest.”